These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 15811118)

  • 1. Daidzein protects endothelial cells against high glucose-induced injury through the dual-activation of PPARα and PPARγ.
    Yang X; Jiang X; Liu C; Yang C; Yao S; Qiu H; Yang J; Wu K; Liao H; Jiang Q
    Gen Physiol Biophys; 2024 Mar; 43(2):153-162. PubMed ID: 38477605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Insights into the Role of PPARγ in Skin Physiopathology.
    Briganti S; Mosca S; Di Nardo A; Flori E; Ottaviani M
    Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered peroxisome-proliferator activated receptors expression in human endometrial cancer.
    Knapp P; Chabowski A; Błachnio-Zabielska A; Jarząbek K; Wołczyński S
    PPAR Res; 2012; 2012():471524. PubMed ID: 22448166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases.
    Ramer R; Hinz B
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer.
    Wagner N; Wagner KD
    Cells; 2022 Aug; 11(15):. PubMed ID: 35954274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FABP7 inhibits proliferation and invasion abilities of cutaneous squamous cell carcinoma cells via the Notch signaling pathway.
    Sun Z; Guo Y; Zhang D; Zhang G; Zhang Y; Wang X
    Oncol Lett; 2022 Aug; 24(2):254. PubMed ID: 35765272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARs and Angiogenesis-Implications in Pathology.
    Wagner N; Wagner KD
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src is activated by the nuclear receptor peroxisome proliferator-activated receptor β/δ in ultraviolet radiation-induced skin cancer.
    Montagner A; Delgado MB; Tallichet-Blanc C; Chan JS; Sng MK; Mottaz H; Degueurce G; Lippi Y; Moret C; Baruchet M; Antsiferova M; Werner S; Hohl D; Saati TA; Farmer PJ; Tan NS; Michalik L; Wahli W
    EMBO Mol Med; 2014 Jan; 6(1):80-98. PubMed ID: 24203162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of biomarkers of human skin ageing in both genders. Wnt signalling - a label of skin ageing?
    Makrantonaki E; Brink TC; Zampeli V; Elewa RM; Mlody B; Hossini AM; Hermes B; Krause U; Knolle J; Abdallah M; Adjaye J; Zouboulis CC
    PLoS One; 2012; 7(11):e50393. PubMed ID: 23226273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention.
    Peters JM; Shah YM; Gonzalez FJ
    Nat Rev Cancer; 2012 Feb; 12(3):181-95. PubMed ID: 22318237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise.
    Sertznig P; Reichrath J
    Dermatoendocrinol; 2011 Jul; 3(3):130-5. PubMed ID: 22110772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma.
    Meyer S; Vogt T; Landthaler M; Berand A; Reichle A; Bataille F; Marx AH; Menz A; Hartmann A; Kunz-Schughart LA; Wild PJ
    PPAR Res; 2009; 2009():848645. PubMed ID: 19639032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of PPARs in Cancer.
    Tachibana K; Yamasaki D; Ishimoto K; Doi T
    PPAR Res; 2008; 2008():102737. PubMed ID: 18584037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome Proliferator-Activated Receptor-gamma Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer.
    Giaginis C; Tsantili-Kakoulidou A; Theocharis S
    PPAR Res; 2008; 2008():431763. PubMed ID: 18464916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARalpha/gamma expression and activity in mouse and human melanocytes and melanoma cells.
    Eastham LL; Mills CN; Niles RM
    Pharm Res; 2008 Jun; 25(6):1327-33. PubMed ID: 18172578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of PPAR nuclear receptors in tissue injury and wound repair.
    Michalik L; Wahli W
    J Clin Invest; 2006 Mar; 116(3):598-606. PubMed ID: 16511592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptors and their ligands: entry into the post-glucocorticoid era of skin treatment?
    Weindl G; Schäfer-Korting M; Schaller M; Korting HC
    Drugs; 2005; 65(14):1919-34. PubMed ID: 16162018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptors in squamous cell carcinoma and its precursors.
    Nijsten T; Geluyckens E; Colpaert C; Lambert J
    J Cutan Pathol; 2005 May; 32(5):340-7. PubMed ID: 15811118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases.
    Nijsten T; Colpaert CG; Vermeulen PB; Harris AL; Van Marck E; Lambert J
    Br J Dermatol; 2004 Oct; 151(4):837-45. PubMed ID: 15491425
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.